Monografie
Combining hiPSC and CRISPR/Cas9 technologies for studying cardiac disease and development
- Sprache
-
Englisch
- Identifier
-
1128309920
Thema
Hochschulschrift
Beteiligte Personen und Organisationen
Dreizehnter, Lisa
Laugwitz, Karl-Ludwig
Moretti, Alessandra
Engelhardt, Stefan
Laugwitz, Karl-Ludwig
Moretti, Alessandra
Engelhardt, Stefan
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:57 MEZ
Objekttyp
- Monografie
Beteiligte
- Dreizehnter, Lisa
- Laugwitz, Karl-Ludwig
- Moretti, Alessandra
- Engelhardt, Stefan
Ähnliche Objekte (12)
Advanced hiPSC-based platforms for in vitro modeling of cardiac development, disease, and therapy
Human iPSC-derived cardiomyocytes as platforms for cardiac disease modeling, therapeutic discovery and safety pharmacology
Characterization of microRNA-365 and -29 and their effect on cardiac hypertrophy
Einfluss von körperlicher Fitness auf die myokardiale diastolische Funktion bei Patienten mit koronarer Herzkrankheit
Patient-Specific Induced Pluripotent Stem-Cell Models of Cardiac Disease
3D Cardiac Tissue Engineering for Studying Hypoplastic Left Heart Syndrome and other Disease Phenotypes
Whole exome sequencing (WES) to elucidate the molecular basis of cardiac disease
Identification of ventricular cardiomyocytes derived from human induced pluripotent stem cells using CRISPR/Cas9
Vorhofvolumina und Pulmonalvenenostien als Prädiktoren für ein Rezidiv von Vorhofflimmern nach einer Pulmonalvenenisolation
Rheumatoid arthritis: the influence of disease activity on clinical and serological parameters
The role of Toll-Like Receptor 2, 4 and 9 in atherosclerosis
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Advanced hiPSC-based platforms for in vitro modeling of cardiac development, disease, and therapy
Human iPSC-derived cardiomyocytes as platforms for cardiac disease modeling, therapeutic discovery and safety pharmacology
Characterization of microRNA-365 and -29 and their effect on cardiac hypertrophy
Einfluss von körperlicher Fitness auf die myokardiale diastolische Funktion bei Patienten mit koronarer Herzkrankheit
Patient-Specific Induced Pluripotent Stem-Cell Models of Cardiac Disease
3D Cardiac Tissue Engineering for Studying Hypoplastic Left Heart Syndrome and other Disease Phenotypes
Whole exome sequencing (WES) to elucidate the molecular basis of cardiac disease
Identification of ventricular cardiomyocytes derived from human induced pluripotent stem cells using CRISPR/Cas9
Vorhofvolumina und Pulmonalvenenostien als Prädiktoren für ein Rezidiv von Vorhofflimmern nach einer Pulmonalvenenisolation
Rheumatoid arthritis: the influence of disease activity on clinical and serological parameters
The role of Toll-Like Receptor 2, 4 and 9 in atherosclerosis
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Advanced hiPSC-based platforms for in vitro modeling of cardiac development, disease, and therapy
Human iPSC-derived cardiomyocytes as platforms for cardiac disease modeling, therapeutic discovery and safety pharmacology
Characterization of microRNA-365 and -29 and their effect on cardiac hypertrophy
Einfluss von körperlicher Fitness auf die myokardiale diastolische Funktion bei Patienten mit koronarer Herzkrankheit
Patient-Specific Induced Pluripotent Stem-Cell Models of Cardiac Disease
3D Cardiac Tissue Engineering for Studying Hypoplastic Left Heart Syndrome and other Disease Phenotypes
Whole exome sequencing (WES) to elucidate the molecular basis of cardiac disease
Identification of ventricular cardiomyocytes derived from human induced pluripotent stem cells using CRISPR/Cas9
Vorhofvolumina und Pulmonalvenenostien als Prädiktoren für ein Rezidiv von Vorhofflimmern nach einer Pulmonalvenenisolation
Rheumatoid arthritis: the influence of disease activity on clinical and serological parameters
The role of Toll-Like Receptor 2, 4 and 9 in atherosclerosis